Visgenx
Visgenx develops therapeutics to protect against the loss of sight from retinal disorders. Its programs are based on increasing the expression of a gene known as ELOVL2 which may regulate aging in cells critical for vision.
Domain
visgenxinc.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$2.8M
Founded
2017
Tech Stack (9 technologies)
Frequently Asked Questions
What technologies does Visgenx use?+
Visgenx uses 9 technologies including Next.js, Cloudflare Browser Insights, React.
What industry is Visgenx in?+
Visgenx operates in the Biotechnology industry.
Where is Visgenx based?+
Visgenx is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026